End Tidal Carbon Dioxide Concentration and Depth of Anesthesia in Children
Launched by UNIVERSITY OF BRITISH COLUMBIA · Mar 6, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different levels of carbon dioxide (CO2) during anesthesia affect how sleepy children feel while they are undergoing surgery. Researchers want to find out if adjusting the CO2 levels can help reduce the amount of anesthesia medication children need. This could lead to safer anesthesia with fewer side effects, lower costs, and a smaller environmental impact by using less disposable equipment.
To participate in this trial, children aged 3 to 11 years who are having non-invasive or minimally-stimulating procedures may be eligible. This includes surgeries like dental work or certain types of ear surgery where they will be given anesthesia without making any cuts or causing pain. Participants will receive anesthesia while being closely monitored, and the study will help doctors understand how CO2 levels can improve the anesthesia experience for kids. If you have any questions about eligibility or the study process, feel free to ask the research team!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged 3 - 11 years undergoing non- or minimally-stimulating elective procedures, defined as anesthesia without skin incision or painful manipulation (e.g., non-invasive imaging, auditory brainstem response testing), middle ear surgery, surgery with effective local or regional anesthesia before surgical incision (e.g dental procedures with local anesthetic infiltration, urology with regional block).
- • American Society of Anesthesiologists (ASA) physical status I and II
- • TIVA technique appropriate throughout induction and maintenance of anesthesia
- • Controlled ventilation via endotracheal tube
- • Anticipated surgical time ≥ 90 minutes: to allow time for anesthetic induction and subsequent testing and washout periods at all three EtCO2 levels.
- Exclusion Criteria:
- • Need for inhalational induction of anesthesia
- • Sedative premedication
- • Use of ketamine intraoperatively
- • Unable to place BIS electrodes due to surgical site or other contraindications (e.g., MRI)
- • Allergy to study drugs (propofol, remifentanil, lidocaine)
- • Depression of conscious level for any reason
- • BMI \<5th or \>95th centile for age
- • History of obstructive or central sleep apnea
- • Known or suspected raised intracranial pressure
- • Recent or historical traumatic brain injury
About University Of British Columbia
The University of British Columbia (UBC) is a leading research institution located in Vancouver, Canada, renowned for its commitment to advancing health sciences through innovative research and education. As a prominent clinical trial sponsor, UBC leverages its interdisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies aimed at improving patient outcomes across various medical fields. The university fosters collaborations with healthcare professionals, industry partners, and community stakeholders to translate research findings into practical applications, thereby contributing to the global advancement of medicine and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Vancouver, British Columbia, Canada
Patients applied
Trial Officials
Christopher A Chin, MBBS, FRCA, FRCP, MA
Principal Investigator
University of British Columbia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported